WHY BIOMARKERS & IMAGING?
Biomarkers and imaging are essential elements of the FDA’s Critical Path Initiative. For more details, click HERE

Biospective and Perceptive Informatics will present a joint poster at the 2011 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in Paris, France on Sunday, July 17, 2011 (12:30-3 p.m.). The title of our poster is:

"Changes in MRI cortical thickness and [18F]FDG PET data over 24 months in subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Study"


BIOSPECTIVE SERVICES

Download printer friendly description of Biospective's services HERE

Alzheimer's Association ICAD 2011
July 16-21, 2011, Paris, France
Visit Us at Booth #35 • Click HERE for more details